Jean Luc Galzi - Publications

Université de Strasbourg 

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Abboud D, Daubeuf F, Do QT, Utard V, Villa P, Haiech J, Bonnet D, Hibert M, Bernard P, Galzi JL, Frossard N. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity. Scientific Reports. 5: 14746. PMID 26442456 DOI: 10.1038/srep14746  0.64
2015 Guilini C, Baehr C, Schaeffer E, Gizzi P, Rufi F, Haiech J, Weiss E, Bonnet D, Galzi JL. New fluorescein precursors for live bacteria detection. Analytical Chemistry. 87: 8858-66. PMID 26260548 DOI: 10.1021/acs.analchem.5b02100  0.64
2015 Galzi JL, Ruggiu F, Gizzi P, Didier B. [Quality control of chemical libraries]. MéDecine Sciences : M/S. 31: 660-6. PMID 26152171 DOI: 10.1051/medsci/20153106020  0.64
2015 Zirafi O, Kim KA, Ständker L, Mohr KB, Sauter D, Heigele A, Kluge SF, Wiercinska E, Chudziak D, Richter R, Moepps B, Gierschik P, Vas V, Geiger H, Lamla M, ... ... Galzi JL, et al. Discovery and characterization of an endogenous CXCR4 antagonist. Cell Reports. 11: 737-47. PMID 25921529 DOI: 10.1016/j.celrep.2015.03.061  0.64
2015 Lecat S, Belemnaba L, Galzi JL, Bucher B. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor. Cellular Signalling. 27: 1297-304. PMID 25817573 DOI: 10.1016/j.cellsig.2015.03.016  0.64
2015 Lecat S, Matthes HW, Pepperkok R, Simpson JC, Galzi JL. A Fluorescent Live Imaging Screening Assay Based on Translocation Criteria Identifies Novel Cytoplasmic Proteins Implicated in G Protein-coupled Receptor Signaling Pathways. Molecular & Cellular Proteomics : McP. 14: 1385-99. PMID 25759509 DOI: 10.1074/mcp.M114.046698  0.64
2014 Romain B, Hachet-Haas M, Rohr S, Brigand C, Galzi JL, Gaub MP, Pencreach E, Guenot D. Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer. Molecular Cancer. 13: 58. PMID 24629239 DOI: 10.1186/1476-4598-13-58  0.64
2014 Ruggiu F, Gizzi P, Galzi JL, Hibert M, Haiech J, Baskin I, Horvath D, Marcou G, Varnek A. Quantitative structure-property relationship modeling: a valuable support in high-throughput screening quality control. Analytical Chemistry. 86: 2510-20. PMID 24479843 DOI: 10.1021/ac403544k  0.64
2014 Michel G, Matthes HW, Hachet-Haas M, El Baghdadi K, de Mey J, Pepperkok R, Simpson JC, Galzi JL, Lecat S. Plasma membrane translocation of REDD1 governed by GPCRs contributes to mTORC1 activation. Journal of Cell Science. 127: 773-87. PMID 24338366 DOI: 10.1242/jcs.136432  0.64
2013 Daval SB, Kellenberger E, Bonnet D, Utard V, Galzi JL, Ilien B. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands. Molecular Pharmacology. 84: 71-85. PMID 23604140 DOI: 10.1124/mol.113.085670  0.64
2013 Daubeuf F, Hachet-Haas M, Gizzi P, Gasparik V, Bonnet D, Utard V, Hibert M, Frossard N, Galzi JL. An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in mice. The Journal of Biological Chemistry. 288: 11865-76. PMID 23449983 DOI: 10.1074/jbc.M112.449348  0.64
2012 Gasparik V, Daubeuf F, Hachet-Haas M, Rohmer F, Gizzi P, Haiech J, Galzi JL, Hibert M, Bonnet D, Frossard N. Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo. Acs Medicinal Chemistry Letters. 3: 10-4. PMID 24900366 DOI: 10.1021/ml200017d  0.64
2012 Galzi JL, Ilien B. [G protein-coupled receptors: allosteric regulators of cell metabolism]. MéDecine Sciences : M/S. 28: 852-7. PMID 23067416 DOI: 10.1051/medsci/20122810013  0.64
2012 Bouchery T, Dénécé G, Attout T, Ehrhardt K, Lhermitte-Vallarino N, Hachet-Haas M, Galzi JL, Brotin E, Bachelerie F, Gavotte L, Moulia C, Bain O, Martin C. The chemokine CXCL12 is essential for the clearance of the filaria Litomosoides sigmodontis in resistant mice. Plos One. 7: e34971. PMID 22511975 DOI: 10.1371/journal.pone.0034971  0.64
2012 Daval SB, Valant C, Bonnet D, Kellenberger E, Hibert M, Galzi JL, Ilien B. Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors. Journal of Medicinal Chemistry. 55: 2125-43. PMID 22329602 DOI: 10.1021/jm201348t  0.64
2012 Galzi JL, Haas M, Frossard N, Hibert M. Why and how to find neutraligands targeting chemokines? Drug Discovery Today: Technologies. 9: e245-e251. DOI: 10.1016/j.ddtec.2012.03.005  0.64
2011 Andersson DA, Gentry C, Alenmyr L, Killander D, Lewis SE, Andersson A, Bucher B, Galzi JL, Sterner O, Bevan S, Högestätt ED, Zygmunt PM. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ(9)-tetrahydrocannabiorcol. Nature Communications. 2: 551. PMID 22109525 DOI: 10.1038/ncomms1559  0.64
2011 Lecat S, Ouédraogo M, Cherrier T, Noulet F, Rondé P, Glasser N, Galzi JL, Mely Y, Takeda K, Bucher B. Contribution of a tyrosine-based motif to cellular trafficking of wild-type and truncated NPY Y(1) receptors. Cellular Signalling. 23: 228-38. PMID 20837140 DOI: 10.1016/j.cellsig.2010.09.007  0.64
2011 Hachet-Haas M, Bonnet D, Daubeuf F, Hibert M, Haiech J, Frossard N, Galzi JL. Neutraligands with the onslaught of chemokines | Les neutraligands à l'assaut des chimiokines Biofutur. 52-55.  0.64
2010 Chow KY, Brotin É, Ben Khalifa Y, Carthagena L, Teissier S, Danckaert A, Galzi JL, Arenzana-Seisdedos F, Thierry F, Bachelerie F. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host & Microbe. 8: 523-33. PMID 21147466 DOI: 10.1016/j.chom.2010.11.006  0.64
2010 Galzi JL, Hachet-Haas M, Bonnet D, Daubeuf F, Lecat S, Hibert M, Haiech J, Frossard N. Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. Pharmacology & Therapeutics. 126: 39-55. PMID 20117133 DOI: 10.1016/j.pharmthera.2009.12.003  0.64
2010 Iturrioz X, Alvear-Perez R, De Mota N, Franchet C, Guillier F, Leroux V, Dabire H, Le Jouan M, Chabane H, Gerbier R, Bonnet D, Berdeaux A, Maigret B, Galzi JL, Hibert M, et al. Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 1506-17. PMID 20040517 DOI: 10.1096/fj.09-140715  0.64
2009 Valant C, Maillet E, Bourguignon JJ, Bucher B, Utard V, Galzi JL, Hibert M. Allosteric functional switch of neurokinin A-mediated signaling at the neurokinin NK2 receptor: structural exploration. Journal of Medicinal Chemistry. 52: 5999-6011. PMID 19746979 DOI: 10.1021/jm900671k  0.64
2009 Ilien B, Glasser N, Clamme JP, Didier P, Piemont E, Chinnappan R, Daval SB, Galzi JL, Mely Y. Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process. The Journal of Biological Chemistry. 284: 19533-43. PMID 19451648 DOI: 10.1074/jbc.M109.017145  0.64
2008 Hachet-Haas M, Balabanian K, Rohmer F, Pons F, Franchet C, Lecat S, Chow KY, Dagher R, Gizzi P, Didier B, Lagane B, Kellenberger E, Bonnet D, Baleux F, Haiech J, ... ... Galzi JL, et al. Small neutralizing molecules to inhibit actions of the chemokine CXCL12. The Journal of Biological Chemistry. 283: 23189-99. PMID 18556651 DOI: 10.1074/jbc.M803947200  0.64
2008 Ouedraogo M, Lecat S, Rochdi MD, Hachet-Haas M, Matthes H, Gicquiaux H, Verrier S, Gaire M, Glasser N, Mély Y, Takeda K, Bouvier M, Galzi JL, Bucher B. Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization. Traffic (Copenhagen, Denmark). 9: 305-24. PMID 18088318 DOI: 10.1111/j.1600-0854.2007.00691.x  0.64
2007 Zoffmann S, Bertrand S, Do QT, Bertrand D, Rognan D, Hibert M, Galzi JL. Topological analysis of the complex formed between neurokinin A and the NK2 tachykinin receptor. Journal of Neurochemistry. 101: 506-16. PMID 17402972 DOI: 10.1111/j.1471-4159.2007.04473.x  0.64
2007 Maillet EL, Pellegrini N, Valant C, Bucher B, Hibert M, Bourguignon JJ, Galzi JL. A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 2124-34. PMID 17371796 DOI: 10.1096/fj.06-7683com  0.64
2007 Kellenberger E, Springael JY, Parmentier M, Hachet-Haas M, Galzi JL, Rognan D. Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. Journal of Medicinal Chemistry. 50: 1294-303. PMID 17311371 DOI: 10.1021/jm061389p  0.64
2006 Bonnet D, Ilien B, Galzi JL, Riché S, Antheaune C, Hibert M. A rapid and versatile method to label receptor ligands using "click" chemistry: Validation with the muscarinic M1 antagonist pirenzepine. Bioconjugate Chemistry. 17: 1618-23. PMID 17105244 DOI: 10.1021/bc060140j  0.64
2006 Hachet-Haas M, Converset N, Marchal O, Matthes H, Gioria S, Galzi JL, Lecat S. FRET and colocalization analyzer--a method to validate measurements of sensitized emission FRET acquired by confocal microscopy and available as an ImageJ Plug-in. Microscopy Research and Technique. 69: 941-56. PMID 17080432 DOI: 10.1002/jemt.20376  0.64
2005 Tahtaoui C, Guillier F, Klotz P, Galzi JL, Hibert M, Ilien B. On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies. Journal of Medicinal Chemistry. 48: 7847-59. PMID 16302823 DOI: 10.1021/jm050459+  0.64
2005 Cluet D, Bertsch C, Beyer C, Gloeckler L, Erhardt M, Gut JP, Galzi JL, Aubertin AM. Detection of human immunodeficiency virus type 1 Nef and CD4 physical interaction in living human cells by using bioluminescence resonance energy transfer. Journal of Virology. 79: 8629-36. PMID 15956605 DOI: 10.1128/JVI.79.13.8629-8636.2005  0.64
2005 Baurand A, Eckly A, Hechler B, Kauffenstein G, Galzi JL, Cazenave JP, Léon C, Gachet C. Differential regulation and relocalization of the platelet P2Y receptors after activation: a way to avoid loss of hemostatic properties? Molecular Pharmacology. 67: 721-33. PMID 15602005 DOI: 10.1124/mol.104.004846  0.64
2005 Galzi JL, Hibert M, De Mey D, Haiech J. How do you enter in clinics? Emergency of discovery of candidates | Comment entrer en clinique? L'urgence de la découverte de candidats médicaments Biofutur. 31-34.  0.64
2004 Cézanne L, Lecat S, Lagane B, Millot C, Vollmer JY, Matthes H, Galzi JL, Lopez A. Dynamic confinement of NK2 receptors in the plasma membrane. Improved FRAP analysis and biological relevance. The Journal of Biological Chemistry. 279: 45057-67. PMID 15294896 DOI: 10.1074/jbc.M404811200  0.64
2004 Tahtaoui C, Parrot I, Klotz P, Guillier F, Galzi JL, Hibert M, Ilien B. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor. Journal of Medicinal Chemistry. 47: 4300-15. PMID 15294002 DOI: 10.1021/jm040800a  0.64
2003 Ilien B, Franchet C, Bernard P, Morisset S, Weill CO, Bourguignon JJ, Hibert M, Galzi JL. Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties. Journal of Neurochemistry. 85: 768-78. PMID 12694403  0.64
2002 Lecat S, Bucher B, Mely Y, Galzi JL. Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses. The Journal of Biological Chemistry. 277: 42034-48. PMID 12185075 DOI: 10.1074/jbc.M203606200  0.64
2002 Zoffmann S, Chollet A, Galzi JL. Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor. Molecular Pharmacology. 62: 729-36. PMID 12181451 DOI: 10.1124/mol.62.3.729  0.64
2002 Gicquiaux H, Lecat S, Gaire M, Dieterlen A, Mély Y, Takeda K, Bucher B, Galzi JL. Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. The Journal of Biological Chemistry. 277: 6645-55. PMID 11741903 DOI: 10.1074/jbc.M107224200  0.64
2001 Palanche T, Ilien B, Zoffmann S, Reck MP, Bucher B, Edelstein SJ, Galzi JL. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. The Journal of Biological Chemistry. 276: 34853-61. PMID 11459843 DOI: 10.1074/jbc.M104363200  0.64
2001 Lukas RJ, Lucero L, Buisson B, Galzi JL, Puchacz E, Fryer JD, Changeux JP, Bertrand D. Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors. The European Journal of Neuroscience. 13: 1849-60. PMID 11403678 DOI: 10.1046/j.0953-816X.2001.01560.x  0.64
2001 Valenzuela-Fernández A, Palanche T, Amara A, Magerus A, Altmeyer R, Delaunay T, Virelizier JL, Baleux F, Galzi JL, Arenzana-Seisdedos F. Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans. The Journal of Biological Chemistry. 276: 26550-8. PMID 11352904 DOI: 10.1074/jbc.M100411200  0.64
2001 Zoffmann S, Turcatti G, Galzi JL, Dahl M, Chollet A. Synthesis and characterization of fluorescent and photoactivatable MIP-1α ligands and interactions with chemokine receptors CCR1 and CCR5 Journal of Medicinal Chemistry. 44: 215-222. PMID 11170631 DOI: 10.1021/jm000982i  0.64
1999 Vollmer JY, Alix P, Chollet A, Takeda K, Galzi JL. Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors. The Journal of Biological Chemistry. 274: 37915-22. PMID 10608858 DOI: 10.1074/jbc.274.53.37915  0.64
1999 Corringer PJ, Bertrand S, Galzi JL, Devillers-Thiéry A, Changeux JP, Bertrand D. Molecular basis of the charge selectivity of nicotinic acetylcholine receptor and related ligand-gated ion channels. Novartis Foundation Symposium. 225: 215-24; discussion 2. PMID 10472058  0.64
1999 Weill C, Galzi JL, Chasserot-Golaz S, Goeldner M, Ilien B. Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors. Journal of Neurochemistry. 73: 791-801. PMID 10428077 DOI: 10.1046/j.1471-4159.1999.0730791.x  0.64
1999 Corringer PJ, Bertrand S, Galzi JL, Devillers-Thiéry A, Changeux JP, Bertrand D. Mutational analysis of the charge selectivity filter of the alpha7 nicotinic acetylcholine receptor. Neuron. 22: 831-43. PMID 10230802 DOI: 10.1016/S0896-6273(00)80741-2  0.64
1999 Weill C, Ilien B, Goeldner M, Galzi JL. Fluorescent muscarinic EGFP-hM1 chimeric receptors: design, ligand binding and functional properties. Journal of Receptor and Signal Transduction Research. 19: 423-36. PMID 10071775 DOI: 10.3109/10799899909036662  0.64
1998 Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, Changeux JP, Bertrand D. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Molecular Pharmacology. 53: 283-94. PMID 9463487  0.64
1996 Galzi JL, Bertrand S, Corringer PJ, Changeux JP, Bertrand D. Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. The Embo Journal. 15: 5824-32. PMID 8918460  0.64
1996 Galzi JL, Edelstein SJ, Changeux J. The multiple phenotypes of allosteric receptor mutants. Proceedings of the National Academy of Sciences of the United States of America. 93: 1853-8. PMID 8700848 DOI: 10.1073/pnas.93.5.1853  0.64
1995 Corringer PJ, Galzi JL, Eiselé JL, Bertrand S, Changeux JP, Bertrand D. Identification of a new component of the agonist binding site of the nicotinic alpha 7 homooligomeric receptor. The Journal of Biological Chemistry. 270: 11749-52. PMID 7744821 DOI: 10.1074/jbc.270.20.11749  0.64
1995 Galzi JL, Changeux JP. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology. 34: 563-82. PMID 7566492 DOI: 10.1016/0028-3908(95)00034-4  0.64
1994 Galzi JL, Changeux JP. Neurotransmitter-gated ion channels as unconventional allosteric proteins Current Opinion in Structural Biology. 4: 554-565. DOI: 10.1016/S0959-440X(94)90218-6  0.64
1993 Aslanian D, Grof P, Galzi JL, Changeux JP. A Raman spectroscopic study of acetylcholine receptor-rich membranes from Torpedo marmorata. Interaction of the receptor with carbamylcholine and (+)-tubocurarine. Biochimica Et Biophysica Acta. 1148: 291-302. PMID 8504123 DOI: 10.1016/0005-2736(93)90142-M  0.64
1993 Eiselé JL, Bertrand S, Galzi JL, Devillers-Thiéry A, Changeux JP, Bertrand D. Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities. Nature. 366: 479-83. PMID 8247158 DOI: 10.1038/366479a0  0.64
1993 Bertrand D, Galzi JL, Devillers-Thiéry A, Bertrand S, Changeux JP. Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proceedings of the National Academy of Sciences of the United States of America. 90: 6971-5. PMID 7688468  0.64
1993 Devillers-Thiéry A, Galzi JL, Eiselé JL, Bertrand S, Bertrand D, Changeux JP. Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. The Journal of Membrane Biology. 136: 97-112. PMID 7508983 DOI: 10.1007/BF02505755  0.64
1993 Bertrand D, Galzi JL, Devillers-Thiéry A, Bertrand S, Changeux JP. Stratification of the channel domain in neurotransmitter receptors. Current Opinion in Cell Biology. 5: 688-93. PMID 7504932 DOI: 10.1016/0955-0674(93)90141-C  0.64
1992 Bertrand D, Devillers-Thiéry A, Revah F, Galzi JL, Hussy N, Mulle C, Bertrand S, Ballivet M, Changeux JP. Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain. Proceedings of the National Academy of Sciences of the United States of America. 89: 1261-5. PMID 1741378  0.64
1992 Changeux JP, Devillers-Thiéry A, Galzi JL, Revah F. The acetylcholine receptor: a model of an allosteric membrane protein mediating intercellular communication. Ciba Foundation Symposium. 164: 66-89; discussion 87. PMID 1395936 DOI: 10.1016/0165-6147(79)90070-1  0.64
1992 Changeux JP, Devillers-Thiéry A, Galzi JL, Bertrand D. New mutants to explore nicotinic receptor functions. Trends in Pharmacological Sciences. 13: 299-301. PMID 1384213 DOI: 10.1016/0165-6147(92)90094-M  0.64
1992 Galzi JL, Devillers-Thiéry A, Hussy N, Bertrand S, Changeux JP, Bertrand D. Mutations in the channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature. 359: 500-5. PMID 1383829 DOI: 10.1038/359500a0  0.64
1992 Changeux JP, Galzi JL, Devillers-Thiéry A, Bertrand D. The functional architecture of the acetylcholine nicotinic receptor explored by affinity labelling and site-directed mutagenesis. Quarterly Reviews of Biophysics. 25: 395-432. PMID 1293635 DOI: 10.1017/S0033583500004352  0.64
1992 Devillers-Thiéry A, Galzi JL, Bertrand S, Changeux JP, Bertrand D. Stratified organization of the nicotinic acetylcholine receptor channel. Neuroreport. 3: 1001-4. PMID 1282832  0.64
1991 Galzi JL, Revah F, Bessis A, Changeux JP. Functional architecture of the nicotinic acetylcholine receptor: from electric organ to brain. Annual Review of Pharmacology and Toxicology. 31: 37-72. PMID 2064379 DOI: 10.1146/  0.64
1991 Galzi JL, Revah F, Bouet F, Ménez A, Goeldner M, Hirth C, Changeux JP. Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proceedings of the National Academy of Sciences of the United States of America. 88: 5051-5. PMID 2052586  0.64
1991 Galzi JL, Bertrand D, Devillers-Thiéry A, Revah F, Bertrand S, Changeux JP. Functional significance of aromatic amino acids from three peptide loops of the alpha 7 neuronal nicotinic receptor site investigated by site-directed mutagenesis. Febs Letters. 294: 198-202. PMID 1756861 DOI: 10.1016/0014-5793(91)80668-S  0.64
1991 Revah F, Bertrand D, Galzi JL, Devillers-Thiéry A, Mulle C, Hussy N, Bertrand S, Ballivet M, Changeux JP. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature. 353: 846-9. PMID 1719423 DOI: 10.1038/353846a0  0.64
1990 Galzi JL, Revah F, Black D, Goeldner M, Hirth C, Changeux JP. Identification of a novel amino acid alpha-tyrosine 93 within the cholinergic ligands-binding sites of the acetylcholine receptor by photoaffinity labeling. Additional evidence for a three-loop model of the cholinergic ligands-binding sites. The Journal of Biological Chemistry. 265: 10430-7. PMID 2355008  0.64
1990 Changeux JP, Benoît P, Bessis A, Cartaud J, Devillers-Thiéry A, Fontaine B, Galzi JL, Klarsfeld A, Laufer R, Mulle C. Regulation of acetylcholine receptor gene expression by neural factors and electrical activity during motor endplate formation. Biochemical Society Symposium. 56: 9-12. PMID 2256962  0.64
1990 Galzi JL, Mejean A, Ilien B, Mollereau C, Meunier JC, Goeldner M, Hirth C. Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor. Journal of Medicinal Chemistry. 33: 2456-64. PMID 2167979  0.64
1990 Galzi JL, Mejean A, Goeldner M, Hirth C, Ilien B. Photoaffinity labelling of the mu-opioid receptor is dependent on the nature of the photosensitive group of carfentanil derivatives. European Journal of Pharmacology. 188: 321-8. PMID 2164936 DOI: 10.1016/0922-4106(90)90192-Z  0.64
1990 Changeux JP, Benoit P, Bessis A, Cartaud J, Devillers-Thiery A, Fontaine B, Galzi JL, Klarsfeld A, Laufer R, Mulle C. The acetylcholine receptor: functional architecture and regulation. Advances in Second Messenger and Phosphoprotein Research. 24: 15-9. PMID 1698404  0.64
1990 Revah F, Galzi JL, Giraudat J, Haumont PY, Lederer F, Changeux JP. The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel. Proceedings of the National Academy of Sciences of the United States of America. 87: 4675-9. PMID 1693775  0.64
1989 Giraudat J, Galzi JL, Revah F, Changeux JP, Haumont PY, Lederer F. The noncompetitive blocker [3H]chlorpromazine labels segment M2 but not segment M 1 of the nicotinic acetylcholine receptor α-subunit Febs Letters. 253: 190-198. PMID 2474458 DOI: 10.1016/0014-5793(89)80957-3  0.64
1988 Ilien B, Galzi JL, Mejean A, Goeldner M, Hirth C. A mu-opioid receptor-filter assay. Rapid estimation of binding affinity of ligands and reversibility of long-lasting ligand-receptor complexes. Biochemical Pharmacology. 37: 3843-51. PMID 2847746 DOI: 10.1016/0006-2952(88)90065-2  0.64
1987 Galzi JL, Ilien B, Simon EJ, Goeldner M, Hirth C. Marquage irreversible des recepteurs des opioides a l'aide de sels d'aryldiazonium derives du fentanyl Tetrahedron Letters. 28: 401-404. DOI: 10.1016/S0040-4039(00)95739-3  0.64
Show low-probability matches.